PCI Biotech Holding ASA (FRA:4QG) Ending Cash Position : €0.00 Mil (As of Jun. 2024)

View and export this data going back to 2008. Start your Free Trial

What is PCI Biotech Holding ASA Ending Cash Position?

PCI Biotech Holding ASA's Ending Cash Position for the quarter that ended in Jun. 2024 was €0.00 Mil.

PCI Biotech Holding ASA's quarterly Ending Cash Position declined from Jun. 2023 (€3.90 Mil) to Dec. 2023 (€0.00 Mil) but then stayed the same from Dec. 2023 (€0.00 Mil) to Jun. 2024 (€0.00 Mil).

PCI Biotech Holding ASA's annual Ending Cash Position declined from Dec. 2021 (€11.44 Mil) to Dec. 2022 (€5.41 Mil) and declined from Dec. 2022 (€5.41 Mil) to Dec. 2023 (€3.58 Mil).

PCI Biotech Holding ASA Ending Cash Position Historical Data

The historical data trend for PCI Biotech Holding ASA's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PCI Biotech Holding ASA Ending Cash Position Chart

PCI Biotech Holding ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

26.04

17.75

11.44

5.41

3.58

PCI Biotech Holding ASA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Jun24
Ending Cash Position	Get a 7-Day Free Trial															5.41	4.53	3.90	-	-

PCI Biotech Holding ASA Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

PCI Biotech Holding ASA's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	4.919	+	-1.339
	=	3.58

PCI Biotech Holding ASA's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0.00

PCI Biotech Holding ASA Ending Cash Position Related Terms

Thank you for viewing the detailed overview of PCI Biotech Holding ASA's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

PCI Biotech Holding ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PCI Biotech Holding ASA (FRA:4QG) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

PCIB:Norway

Address

Ullernchausseen 64, Oslo, NOR, N-0379

Website

https://www.pcibiotech.com

PCI Biotech Holding ASA is a biopharmaceutical company focused on developing and commercializing cancer therapies using its photochemical internalization (PCI) technology platform. The PCI technology utilizes light to trigger the release of compounds from within cellular compartments. The company applies PCI to three different approaches for cancer treatment: fimaCHEM: Enhancing chemotherapeutic drugs for localized cancer treatment. fimaVACC: Inducing T-cell responses for therapeutic cancer vaccination. fimaNAc: Delivering nucleic acid therapeutics. The key product candidate is fimaporfin (Amphinex), a photosensitizer that can unlock intracellular compartments where active compounds are trapped. The company's sole operating segment is research and development.

PCI Biotech Holding ASA Headlines

No Headlines